PTH Comparison in Post Menopausal Women

PHASE3CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

June 30, 2004

Conditions
Osteoporosis, Post-Menopausal
Interventions
DRUG

teriparatide 20 micrograms/day subcutaneous

DRUG

calcitonin 100 IU/day subcutaneous

Trial Locations (4)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) Mon-Fri from 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Changhua

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) Mon-Fri from 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Niao Sung Hsiang

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) Mon-Fri from 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Taipei

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) Mon-Fri from 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Taoyuan District

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00543218 - PTH Comparison in Post Menopausal Women | Biotech Hunter | Biotech Hunter